New Tools in Diagnosis and Therapy


In the future, the Identification of the biochemical and molecular factors and related genes linked to the onset and progression of diseases (biomarkers) will guide the choice of therapies and also the segregation of patients who are most likely to benefit from a given therapy. The development of biomarkers for diseases (with a particular focus on cancer and rare diseases) would probably overcome the current limitations in the technologies of genomics and proteomics, and may change the practice of Clinical Medicine, with unforeseen economic consequences.

Area coordinator:

Prof. Ángel Rodríguez de Lera

Organic Chemist.

More info: Organic ChemistryCINBIO


David Posada. More info: Phylogenomics

Florentino Fernández Riverola. More info: Bioinformatics

Ana Gago Martinez. More info: Analytical and Food ChemistryCINBIO

Lines of research:

  • Epigenetic changes in diseases.
  • Synthesis of epigenetic modulators.
  • Pharmacogenomics and pharmacogenetics of diseases.
  • New biosensors.
  • New tools for biomedical applications.
  • Data analysis (genomic/proteomics)



Friday, June 5, 2015
Researchers meeting at the BIOCAPS seminar agree that these tools will be key to tumour diagnosis and treatment
Wednesday, May 27, 2015
Free registration is open for the final two scientific seminars organised by IBI before summer
Tuesday, April 14, 2015
The company Irida is constructing a prototype of the device and will fund research to establish the exact malignancy parameters by way of trials with patients